Management of ocular stem cell disease

International Ophthalmology Clinics

Volumn 50, Issue 3, 2010, Pages 25-34

  Biber, Joseph M ^a   Holland, Edward J ^a   Neff, Kristiana D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS;

AMNIOTIC MEMBRANE TRANSPLANTATION; CONJUNCTIVAL LIMBAL ALLOGRAFT; CONJUNCTIVAL LIMBAL AUTOGRAFT; EX VIVO STUDY; EYE DISEASE; EYE SURGERY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOLIMBAL ALLOGRAFT; KERATOPLASTY; LIVING DONOR; OCULAR STEM CELL DISEASE; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; CORNEA EPITHELIUM; CORNEA LIMBUS; CORNEAL DISEASES; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STEM CELL; TRANSPLANTATION;

CORNEAL DISEASES; EPITHELIUM, CORNEAL; HUMANS; LIMBUS CORNEAE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77954642741     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181e20d64     Document Type: Review

References (26)

1. Schwartz GS, Gomes JAP, Holland EJ. Preoperative staging of disease severity. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease. New York: Springer; 2002.
2. Schwartz GS, Holland EJ. Iatrogenic limbal stemcell deficiency. Cornea. 1998;17:31-37.
3. Margo CE. Congenital aniridia: a histopathologic study of the anterior segment in children. J Pediatr Ophthalmol Strabismus. 1983;20:192-198.
4. Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Trans Am Ophthalmol Soc. 1996;44:677-743.
5. Holland EJ, Schwartz GS. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea. 1996;15:549-556.
6. Jenkins C, Tuft S, Liu C, et al. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy. Eye. 1993;7:629-663.
7. Chen JJ, Tseng SC. Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol Vis Sci. 1990;31:1301-1314.
8. Shimazaki J, Shimmura S, Fujishima H, et al. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology. 2000;107: 1518-1523.
9. Tsubota K, Shimazaki J. Surgical treatment of children blinded by Stevens-Johnson syndrome. Am J Opthalmol. 1999;128:573-581.
10. Wei Z-G, Sun T-T, Lavker RM. Rabbit conjunctival corneal epithelial cells belong to two separate lineages. Invest Ophthalmol Vis Sci. 1996;37:523-533.
11. Schwartz GS, Tsubota K, Tseng SCG, et al. Keratolimbal allograft. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease. New York: Springer; 2002.
12. Aldave AJ, Wong IG. A novel technique for harvesting keratolimbal allografts from corneoscleral buttons. Am J Ophthalmol. 2002;134:929-931.
13. Lim LT, Bhatt PR, Ramaesh K. Harvesting keratolimbal allografts from corneoscleral buttons: a novel application of cyanoacrylate adhesive. Br J Ophthalmol. 2008;92:1550-1551.
14. Holland EJ, Schwartz GS, Djalilian AR. Combination KLAL and lr-CLAL for the Management of Severe Ocular Surface Disease. New Orleans, LAL: EBAA-Castroviejo Cornea Society Symposium; 2001.
15. Fukuda K, Chikama T, Nakamura M, et al. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73-79.
16. Kim JS, Kim JC, Na BK, et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70:329-337.
17. Prabhasawat P, Tseng SC. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol. 1997;115:1360-1367.
18. Lee SB, Li DQ, Tan DT, et al. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. 2000;20:325-334.
19. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179: 325-335.
20. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
21. Kruse FE, Rohrschneider K, Volcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology. 1999;106:1504-1510.
22. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002;21: 342-345.
23. Djalian AR, Bagheri MM, Swanson PJ, et al. Keratolimbal allograft for the treatment of limbal stem cell deficiency. Oral presentation, Castroviejo Cornea Society Annual Meeting, October 1999, Orlando, FL.
24. Holland EJ, Mogilishetty G, Alloway R, et al. A decade of immunosuppression in patients undergoing ocular surface transplants. Oral Presentation, Symposium on Eye Banking and Cornea, October 2009, San Francisco, CA.
25. Croasdale CR, Schwartz GS, Malling JV, et al. Keratolimbal allograft: recommendations for tissue procurement and preparation by eye banks, and standard surgical technique. Cornea. 1999;18:52-58.
26. Shimazaki J, Shimmura S, Tsubota K. Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea. Ophthalmology. 2004; 11:38-44.